Treace Medical Concepts, Inc. - Common Stock (NQ:TMCI)

4.390 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Treace Medical Concepts, Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Treace Publishes Inaugural ESG Report

April 04, 2023

From Treace Medical Concepts, Inc.

Via GlobeNewswire

Why Treace Medical Concepts' Shares Rose Wednesday ↗

March 08, 2023

The company's Lapiplasty surgery kits are driving increased revenue.

Via The Motley Fool

Why Miromatrix Medical Shares Are Trading Lower By 40%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

March 08, 2023

Gainers Kimball International, Inc. (NASDAQ: KBAL) shares jumped 84.9% to $12.40 after HNI Corporation announced it will acquire the company for $485 million.

Via Benzinga

A Preview Of Treace Medical Concepts's Earnings ↗

March 06, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

March 08, 2023

Via Benzinga

Mesoblast, Arlo Technologies, CPI Card Group And Other Big Stocks Moving Higher On Wednesday ↗

March 08, 2023

U.S. stocks traded mixed, with the Nasdaq Composite gaining around 30 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

March 08, 2023

Via Benzinga

Treace Medical Concepts Reports Fourth Quarter and Full Year 2022 Financial Results

March 07, 2023

From Treace Medical Concepts, Inc.

Via GlobeNewswire

Treace Medical Announces Settlement of Lawsuit Again Fusion Orthopedics

March 03, 2023

From Treace Medical Concepts, Inc.

Via GlobeNewswire

Treace to Report Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023

February 27, 2023

From Treace Medical Concepts, Inc.

Via GlobeNewswire

Treace Presents Updated ALIGN3D™ Interim Data and Latest Product Innovations at the 2023 ACFAS Annual Conference

February 09, 2023

From Treace Medical Concepts, Inc.

Via GlobeNewswire

Why Treace Medical Concepts Stock Is Trading Lower ↗

February 08, 2023

Treace Medical Concepts Inc (NASDAQ: TMCI) shares are trading lower by 8.48% to $21.05 Wednesday morning after the company announced a proposed $100 million common stock offering. What Happened?

Via Benzinga

Treace Medical Concepts, Inc. Announces Pricing of $100.0 Million Public Offering of Common Stock

February 07, 2023

From Treace Medical Concepts, Inc.

Via GlobeNewswire

Why Treace Medical Concepts (TMCI) Shares Are Falling During Tuesday's After-Hours Session ↗

February 07, 2023

Treace Medical Concepts Inc (NASDAQ: TMCI) shares are trading lower by 6.52% to $21.50 during Tuesday's after-hours session. The company announced a proposed $100 million common stock offering.

Via Benzinga

Treace Medical Concepts, Inc. Announces Proposed Public Offering of Common Stock

February 07, 2023

From Treace Medical Concepts, Inc.

Via GlobeNewswire

NASDAQ:TMCI Shareholder Alert: Investigation over Potential Wrongdoing at Treace Medical Concepts, Inc. ↗

January 27, 2023

San Diego, CA -- (SBWIRE) -- 01/27/2023 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Treace Medical Concepts, Inc.

Via SBWire

Treace Medical Concepts Provides 2022 Preliminary Unaudited Revenue

January 09, 2023

From Treace Medical Concepts, Inc.

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Is Investigating BRP, Alico, Treace, and Welltower and Encourages Investors to Contact the Firm

January 08, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

TREACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Treace Medical Concepts, Inc. on Behalf of Treace Stockholders and Encourages Investors to Contact the Firm

December 30, 2022

From Bragar Eagel & Squire

Via GlobeNewswire

Treace to Present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023

December 20, 2022

From Treace Medical Concepts, Inc.

Via GlobeNewswire

Treace Medical Announces Expansion of Its Global IP Portfolio with the Grant of Two New U.S. Patents

December 19, 2022

From Treace Medical Concepts, Inc.

Via GlobeNewswire

NASDAQ:TMCI Investor Notice: Investigation over Possible Securities Laws Violations by Treace Medical Concepts, Inc. ↗

December 05, 2022

San Diego, CA -- (SBWIRE) -- 12/05/2022 -- Treace Medical Concepts, Inc. is under investigation over potential securities laws violations in connection with certain financial statements.

Via SBWire

Treace Receives FDA 510(k) Clearance for SpeedPlate™ Rapid Compression Implant Technology

November 28, 2022

From Treace Medical Concepts, Inc.

Via GlobeNewswire

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Treace Medical Concepts, Inc. and Encourages Investors with Losses to Contact the Firm

November 22, 2022

From The Schall Law Firm

Via Business Wire

Treace Announces First Patient Treated in MTA3D™ Adductoplasty® Clinical Study

November 21, 2022

From Treace Medical Concepts, Inc.

Via GlobeNewswire

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Treace Medical Concepts, Inc. and Encourages Investors with Losses to Contact the Firm

November 21, 2022

From The Schall Law Firm

Via Business Wire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

November 16, 2022

Via Benzinga

Vodafone, Getty Images Holdings, Haynes International And Some Other Big Stocks Moving Lower On Tuesday ↗

November 15, 2022

U.S. stocks traded higher, with the Nasdaq gaining more than 200 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From Yesterday ↗

November 16, 2022

Gainers Satixfy Communications Ltd. (NYSE: SATX) shares gained 140.7% to settle at $31.80 on Tuesday.

Via Benzinga

Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 67 Stocks Moving In Tuesday's Mid-Day Session ↗

November 15, 2022

Gainers SenesTech, Inc. (NASDAQ: SNES) shares surged 91.7% to $0.2751. SenesTech reported a 1-for-20 reverse stock split.

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.